A novel LRRK2 mutation in a mainland Chinese patient with familial Parkinson's disease
- 14 January 2010
- journal article
- research article
- Published by Elsevier BV in Neuroscience Letters
- Vol. 468 (3), 198-201
- https://doi.org/10.1016/j.neulet.2009.10.080
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Clinical and pathological characteristics of patients with Leucine‐rich repeat kinase‐2 mutationsMovement Disorders, 2009
- LRRK2 R1628P increases risk of Parkinson’s disease: replication evidenceHuman Genetics, 2008
- Mutations in the GIGYF2 (TNRC15) Gene at the PARK11 Locus in Familial Parkinson DiseaseAmerican Journal of Human Genetics, 2008
- Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controlsHuman Molecular Genetics, 2008
- Leucine-Rich Repeat kinase 2 G2385R variant is a risk factor for Parkinson disease in Asian populationNeuroReport, 2007
- The LRRK2 Gly2385Arg variant is associated with Parkinson’s disease: genetic and functional evidenceHuman Genetics, 2006
- A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson’s disease risk in Taiwanneurogenetics, 2006
- Clinicogenetic study of mutations inLRRK2 exon 41 in Parkinson's disease patients from 18 countriesMovement Disorders, 2006
- UCHL‐1 is not a Parkinson's disease susceptibility geneAnnals of Neurology, 2006
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997